Literature DB >> 16983269

Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis.

Manfred Weiss, E Marion Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16983269     DOI： 10.1097/01.CCM.0000240242.10583.86

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

1.  CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma.

Authors:  Chaoya Ma; Hasita Horlad; Koji Ohnishi; Takenobu Nakagawa; Sohsuke Yamada; Shohei Kitada; Takanobu Motoshima; Tomomi Kamba; Toshiyuki Nakayama; Naohiro Fujimoto; Motohiro Takeya; Yoshihiro Komohara
Journal:  Med Mol Morphol       Date:  2017-07-07       Impact factor: 2.309

2.  CD163 deficiency facilitates lipopolysaccharide-induced inflammatory responses and endotoxin shock in mice.

Authors:  Yukio Fujiwara; Koji Ohnishi; Hasita Horlad; Yoichi Saito; Daisuke Shiraishi; Hiroto Takeya; Daiki Yoshii; Shinjiro Kaieda; Tomoaki Hoshino; Yoshihiro Komohara
Journal:  Clin Transl Immunology       Date:  2020-09-25

3.  Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.

Authors:  Catherine Ingels; Holger J Møller; Troels K Hansen; Pieter J Wouters; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  J Clin Immunol       Date:  2012-11-13       Impact factor: 8.317

4.  Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease.

Authors:  Milene T Saavedra; Grant J Hughes; Linda A Sanders; Michelle Carr; David M Rodman; Christopher D Coldren; Mark W Geraci; Scott D Sagel; Frank J Accurso; James West; Jerry A Nick
Journal:  Am J Respir Crit Care Med       Date:  2008-08-21       Impact factor: 21.405

5.  Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.

Authors:  Anders G Kjærgaard; Sidsel Rødgaard-Hansen; Anders Dige; Jan Krog; Holger J Møller; Else Tønnesen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.